283
Views
0
CrossRef citations to date
0
Altmetric
Research Article

SCN1A IVS5N+5 Polymorphism and Response to Sodium Valproate: A Multicenter Study

, , , , , , & show all
Pages 1477-1485 | Published online: 12 Oct 2012

References

  • Kwan P , SchachterSC, BrodieMJ. Drug-resistant epilepsy. N. Engl. J. Med.365 , 919–926 (2011).
  • Löscher W . Mechanisms of drug resistance. Epileptic Disord.7(Suppl. 1) , S3–S9 (2005).
  • Lasoń W , Dudra-JastrzębskaM, RejdakK et al. Basic mechanisms of antiepileptic drugs and their pharmacokinetic/pharmacodynamic interactions: an update. Pharmacol. Rep. 63 , 271–292 (2011).
  • Rosenberg G . The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? Cell. Mol. Life Sci.64 , 2090–2103 (2007).
  • Chateauvieux S , MorceauF, DicatoM et al. Molecular and therapeutic potential and toxicity of valproic acid. J. Biomed. Biotechnol. pii , 479364 (2010).
  • Catterall WA . Voltage-gated sodium channels at 60: structure, function, and pathophysiology. J. Physiol.1 , 2577–2589 (2012).
  • Osaka H , OgiwaraI, MazakiE et al. Patients with a sodium channel α 1 gene mutation show wide phenotypic variation. Epilepsy Res. 75 , 46–51 (2007).
  • Catterall WA , KalumeF, OakleyJC. Ion channel voltage sensors: structure, function, and pathophysiology. Neuron67 , 915–928 (2010).
  • Payandeh J , ScheuerT, ZhengN et al. The crystal structure of a voltage-gated sodium channel. Nature 475 , 353–358 (2007).
  • Mantegazza M , CuriaG, BiaginiG et al. Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders. Lancet Neurol. 9 , 413–424 (2010).
  • Zuliani V , FantiniM, RivaraM. Sodium channel blockers as therapeutic target for treating epilepsy: recent updates. Curr. Top Med. Chem.12 , 962–970 (2012).
  • Zhang W , DuanS, BleibelWK et al. Identification of common genetic variants that account for transcript isoform variation between human populations. Hum. Genet. 125 , 81–93 (2009).
  • Copley RR . Evolutionary convergence of alternative splicing in ion channels. Trends Genet.20 , 171–176 (2004).
  • Tan J , LiuZ, NomuraY, GoldinAL et al. Alternative splicing of an insect sodium channel gene generates pharmacologically distinct sodium channels. J. Neurosci. 22 , 5300–5309 (2002).
  • Fletcher EV , KullmannDM, SchorgeS. Alternative splicing modulates inactivation of type 1 voltage-gated sodium channels by toggling an amino acid in the first S3–S4 linker. J. Biol. Chem.286 , 36700–36708 (2011).
  • Tate SK , DepondtC, SisodiyaSM et al. Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin. Proc. Natl Acad. Sci. USA 102 , 5507–5512 (2005).
  • Heinzen EL , YoonW, TateSK et al. Nova2 interacts with a cis-acting polymorphism to influence the proportions of drug-responsive splice variants of SCN1A. Am. J. Hum. Genet. 80 , 876–883 (2007).
  • Tate SK , SinghR, HungCC et al. A common polymorphism in the SCN1A gene associates with phenytoin serum levels at maintenance dose. Pharmacogenet. Genomics 16 , 721–726 (2006).
  • Krikova EV , Val‘dmanEA, AvakianGN et al. Association study of the SCN1 gene polymorphism and effective dose of lamotrigine. Zh. Nevrol. Psikhiatr. Im. S S Korsakova 109 , 57–62 (2009).
  • Zimprich F , StogmannE, BonelliS et al. A functional polymorphism in the SCN1A gene is not associated with carbamazepine dosages in Austrian patients with epilepsy. Epilepsia 49 , 1108–1109 (2008).
  • Abe T , SeoT, IshitsuT et al. Association between SCN1A polymorphism and carbamazepine-resistant epilepsy. Br. J. Clin. Pharmacol. 66 , 304–307 (2008).
  • Kwan P , PoonWS, NgHK et al. Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expression. Pharmacogenet. Genomics 18 , 989–998 (2008).
  • Sánchez MB , HerranzJL, LenoC et al. Genetic factors associated with drug-resistance of epilepsy: relevance of stratification by patient age and aetiology of epilepsy. Seizure 19 , 93–101 (2010).
  • Manna I , GambardellaA, BianchiA et al. A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy. Epilepsia 52 , e40–e44 (2011).
  • Thompson CH , KahligKM, GeorgeAL Jr. SCN1A splice variants exhibit divergent sensitivity to commonly used antiepileptic drugs. Epilepsia52 , 1000–1009 (2011).
  • Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia22 , 489–501 (1981).
  • Panayiotopoulos CP . The new ILAE report on terminology and concepts for organization of epileptic seizures: a clinician‘s critical view and contribution. Epilepsia52 , 2155–2160 (2011).
  • Kwan P , ArzimanoglouA, BergAT et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51 , 1069–1077 (2009).
  • Bax L , YuLM, IkedaN et al. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med. Res. Methodol. 6 , 1–11 (2006).

▪ Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.